Who Paid My Doc
Mark Brodie
Therapeutic Radiology Houston, TX Medical Doctor
NPI 1700857679 CMS profile 349898
2190 North Loop W, Houston, TX 77018
General payments
$2,790
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Mark Brodie of Houston, TX is reported in the CMS Open Payments database as having received $2,790 across 40 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 79th percentile of Therapeutic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $465 | 4 | |
| 2024 | General | $355 | 4 | |
| 2023 | General | $214 | 4 | |
| 2022 | General | $913 | 11 | |
| 2021 | General | $371 | 8 | |
| 2020 | General | $164 | 3 | |
| 2019 | General | $308 | 6 |
Beside peers
- Mark Brodie
- Therapeutic Radiology median
- Middle half of Therapeutic Radiology
- National median
In program year 2025, general payments to Mark Brodie were reported at $465. Among 82 Therapeutic Radiology profiles paid that year, the median was $179 and the middle half received between $54 and $602.
Show as a table
| Year | Mark Brodie | Therapeutic Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $308 | $108 | $31–$339 | $163 |
| 2020 | $164 | $48 | $28–$197 | $114 |
| 2021 | $371 | $72 | $23–$391 | $132 |
| 2022 | $913 | $77 | $31–$399 | $149 |
| 2023 | $214 | $148 | $55–$613 | $160 |
| 2024 | $355 | $172 | $45–$795 | $164 |
| 2025 | $465 | $179 | $54–$602 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 159 billing codesPaid by Medicare
$127,984
Medicare patients
3,830
Services billed
5,064
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 60% | |
| Ischemic heart disease | 59% | |
| Chronic kidney disease | 50% | |
| Heart failure | 47% | |
| Diabetes | 46% | |
| Atrial fibrillation | 39% | |
| COPD | 34% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
40 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Therapeutic Radiology in Texas
William Morrison
Therapeutic Radiology · Houston, TX
Jack Phan
Therapeutic Radiology · Houston, TX
Sidney Roberts
Therapeutic Radiology · Lufkin, TX
Nyun Han
Therapeutic Radiology · El Paso, TX
Michael Dullea
Therapeutic Radiology · Fort Sam Houston, TX
David Janssen
Therapeutic Radiology · Victoria, TX
Related records
Therapeutic Radiology in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Therapeutic Radiology
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.